Epicrispr Biotechnologies specializes in developing gene-modulating therapies, focusing on treatments for facioscapulohumeral muscular dystrophy (FSHD) using their proprietary Gene Expression Modulation System (GEMS).

Cardiac Dimensions develops and commercializes the Carillon Mitral Contour System, a minimally invasive device for treating functional mitral regurgitation in heart failure patients.

VitalConnect, Inc. develops advanced biosensor technology for remote and in-patient cardiac monitoring solutions.

RefleXion Medical develops and commercializes SCINTIX therapy, a novel treatment for all stages of indicated solid tumor cancers, including metastatic disease, delivered via the RefleXion X1 platform.

Vida Health provides a clinical care platform that combines AI-powered mobile apps with a national network of providers to treat and manage cardiometabolic conditions and related mental health conditions.

CMR Surgical is a UK-based company that develops and commercializes a surgical robotic system, Versius®, used in various surgical specialties in hospitals worldwide.